{"nct_id":"NCT01047345","title":"A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)","status":"COMPLETED","status_verified_date":"2018-10","start_date":"2010-02-24","start_date_type":"ACTUAL","primary_completion_date":"2011-06-10","primary_completion_date_type":"ACTUAL","completion_date":"2015-11-28","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}